Related Experiment Video
Updated: Aug 18, 2026
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The novel phospholipase C activator, m-3M3FBS, induces monocytic leukemia cell apoptosis
Youl-Nam Lee1, Ha-Young Lee, Jae-Seok Kim
1Medical Research Center for Cancer Molecular Therapy, College of Medicine, Dong-A University, Busan 602-714, South Korea.
Abstract:
We investigated the effect of the novel phospholipase C activator, m-3M3FBS, on the apoptosis of leukemic cells. m-3M3FBS inhibited the growth of the leukemic cell lines U937 and THP-1, but not primary monocytes. m-3M3FBS induced the apoptosis of U937 cells, which was accompanied by chromatin condensation and DNA fragmentation. Moreover, m-3M3FBS-induced apoptosis appeared to involve the down-regulation of anti-apoptotic Bcl-2, the up-regulation of pro-apoptotic Bax, the release of cytochrome c, and caspase activation. m-3M3FBS-induced apoptosis of U937 cells was also partly inhibited by BAPTA-AM and EGTA, indicating the involvement of intracellular calcium signaling on the apoptosis in U937 cells. The results of our study suggest that m-3M3FBS can be developed as a novel anti-leukemic agent.
Insights
The novel compound m-3M3FBS inhibits leukemic cell growth and induces apoptosis by affecting Bcl-2, Bax, and caspase pathways. This suggests its potential as a new anti-leukemic therapeutic agent.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Leukemia remains a significant health challenge, necessitating the development of novel therapeutic agents.
- Understanding the molecular mechanisms of apoptosis in leukemic cells is crucial for targeted therapy development.
Purpose of the Study:
- To investigate the effects of the novel phospholipase C activator, m-3M3FBS, on leukemic cell apoptosis.
- To elucidate the molecular pathways involved in m-3M3FBS-induced apoptosis.
Main Methods:
- Treatment of leukemic cell lines (U937, THP-1) and primary monocytes with m-3M3FBS.
- Assessment of cell growth inhibition, apoptosis induction (chromatin condensation, DNA fragmentation).
- Analysis of apoptosis-related protein expression (Bcl-2, Bax), cytochrome c release, caspase activation, and intracellular calcium signaling.
Main Results:
- m-3M3FBS inhibited the growth of U937 and THP-1 leukemic cell lines but not primary monocytes.
- m-3M3FBS induced apoptosis in U937 cells, characterized by chromatin condensation and DNA fragmentation.
- Apoptosis involved Bcl-2 down-regulation, Bax up-regulation, cytochrome c release, caspase activation, and was partly mediated by intracellular calcium signaling.
Conclusions:
- m-3M3FBS effectively induces apoptosis in specific leukemic cell lines.
- The compound's mechanism involves modulation of key apoptotic proteins and calcium signaling.
- m-3M3FBS shows promise as a potential novel anti-leukemic agent.